Related Experiment Videos
[Lp(a) and the cardiovascular risk in dyslipidemia subjects]
L Arsenio1, F Cioni, G G Japichino
1Centro per lo Studio e la Terapia delle Dislipidemie, Azienda Ospedaliera, Parma.
Insights
Elevated levels of lipoprotein(a) (Lp(a)) are linked to coronary heart disease (CHD) but not peripheral vascular disease (PVD) in dyslipidaemic patients. This finding highlights Lp(a) as a significant risk factor for heart disease.
Area of Science:
- Cardiovascular Medicine
- Clinical Biochemistry
- Lipidology
Context:
- Dyslipidaemic patients present complex cardiovascular risk profiles.
- Lipoprotein(a) [Lp(a)] is an emerging independent risk factor for atherosclerotic diseases.
- Understanding Lp(a) associations is crucial for risk stratification.
Purpose:
- To investigate the correlation between plasma Lp(a) levels and peripheral vascular disease (PVD) and/or coronary heart disease (CHD).
- To assess Lp(a) levels in relation to stenotic lesions in carotid and femoral arteries and ECG signs of coronary ischemia.
Summary:
- Plasma Lp(a) levels were measured in 20 dyslipidaemic patients.
- No significant difference in Lp(a) was found between patients with and without carotid/femoral artery stenotic lesions.
- Lp(a) levels were significantly higher in patients with ECG-diagnosed coronary ischemic heart disease compared to those with normal ECGs.
Impact:
- Confirms Lp(a) as a significant risk factor specifically for coronary heart disease in dyslipidaemic individuals.
- Suggests Lp(a) may not be a primary indicator for peripheral vascular disease in this cohort.
- Informs clinical practice regarding cardiovascular risk assessment and management in dyslipidaemia.
Abstract:
In this paper the presence of a correlation between plasma Lp(a) levels and peripheral vascular disease (PVD) and/or coronary heart disease (CHD) was investigated in 20 dyslipidaemic patients (10 males and 10 females, well matched for age, type of hyperlydaemia and other CVD risk factors). Lp(a) plasma levels, ECG and carotid and femoral arteries duplex ultrasonography were performed in all the patients. No difference in plasma Lp(a) levels between patients without and with carotid and femoral arteries stenotic lesions was observed. On the contrary Lp(a) was significantly higher in patients with ECG signs of coronary ischaemic heart diseases than in patients with normal ECG. These observations confirm the importance of Lp(a) as a risk factor for coronary heart disease in dyslipidaemic patients.